ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

The Von Clauss Assay Does Not Accurately Measure Total Fibrinogen Levels After Traumatic Injury. Have We Been Thinking About Fibrinogen Replacement All Wrong?

M. DeBot1, I. Lacroix2, A. D'Alessandro3, E. Moore4, C. Silliman2, A. Sauaia2, T. Schaid5, C. Erickson2, A. Cralley2, M. Cohen2, K. Hansen2

1University of Colorado, aurora, Colorado, United States, 2University of Colorado, Aurora, Colorado, United States, 3Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States, 4Ernest E Moore Shock Trauma Center atDenver Health, Denver, Colorado, United States, 5University of Colorado, Denver, Colorado, United States

Abstract Number: OC 67.5

Meeting: ISTH 2022 Congress

Theme: Coagulation and Natural Anticoagulants » Critical Care and Perioperative

Background: The Von Clauss assay (FbVC), which estimates fibrinogen concentration based on the rate of thrombin-induced fibrin polymerization, is the standard clinical fibrinogen measurement. During acute physiological stress, oxidation alters the capacity of fibrinogen for fibrin polymerization and thus decreases the accuracy of FbVC. To date, there are no reports on the accuracy of FbVC after trauma.

Aims: Our aim was to evaluate the accuracy of FbVC versus total fibrinogen levels measured via mass spectrometry (FbMS). We hypothesized that severe injury reduces the accuracy of FbVC, and that fibrinogen repletion increases total fibrinogen levels without improving fibrin polymerization.

Methods: Blood was collected from injured patients at a level I trauma center in the ED, and at 6 and 24hr after hospital arrival. Fibrinogen levels were measured via targeted liquid chromatography coupled with mass spectrometry and analyzed with clinical data, treatments, outcomes, and FbVC.

Results: At 6hr after injury, patients who received cryoprecipitate showed a 13% increase in FbMS while patients who did not receive cryoprecipitate showed no change in FbMS (p=0.03, figure 1). No significant difference was seen in FbVC between patients who did and did not receive cryoprecipitate. Patients with minor trauma (NISS < 15, BE >-10 or INR < 1.4) showed correlations between FbMS and FbVC which were similar to healthy controls (Figure 2); whereas severely injured patients with shock or coagulopathy had poor correlations between FbMS and FbVC.

Conclusion(s): The Von Clauss Assay underestimates fibrinogen levels in hemorrhagic shock. Decreases in FbVC may reflect impaired fibrinogen polymerization rather than decreased availability and therefore FbVC may not respond to fibrinogen replacement. FbVC should be used with caution to guide fibrinogen replacement during resuscitation and correcting shock and the oxidative milieu of trauma may be more effective at improving fibrin polymerization than fibrinogen repletion alone.

To cite this abstract in AMA style:

DeBot M, Lacroix I, D'Alessandro A, Moore E, Silliman C, Sauaia A, Schaid T, Erickson C, Cralley A, Cohen M, Hansen K. The Von Clauss Assay Does Not Accurately Measure Total Fibrinogen Levels After Traumatic Injury. Have We Been Thinking About Fibrinogen Replacement All Wrong? [abstract]. https://abstracts.isth.org/abstract/the-von-clauss-assay-does-not-accurately-measure-total-fibrinogen-levels-after-traumatic-injury-have-we-been-thinking-about-fibrinogen-replacement-all-wrong/. Accessed October 1, 2023.

« Back to ISTH 2022 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/the-von-clauss-assay-does-not-accurately-measure-total-fibrinogen-levels-after-traumatic-injury-have-we-been-thinking-about-fibrinogen-replacement-all-wrong/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress ยป

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley